FDA Import Refusal 799-6747046-8/11/2 — NOVARTIS PHARMACEUTICALS N2
The FDA refused shipment 799-6747046-8/11/2 from NOVARTIS PHARMACEUTICALS N2 (New Zealand) on Feb 9, 2022. The refused product falls under Drugs and Biologics — GLIPIZIDE (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 2 other import refusals on record.
Refusal details
- Date
- Feb 9, 2022
- Country
- New Zealand
- Product Category
- Drugs and Biologics
- Product Code
- 61PDB09 GLIPIZIDE (ANTI-DIABETIC)
- Charges
- 118,3280